Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs SpaceX (SPCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs SpaceX — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.88 (market cap $25.27B), while SpaceX trades at $162.57 (market cap $2.18T). The key difference: SpaceX is far larger — about 86.3× Royalty Pharma plc Class A Ordinary Shares's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while SpaceX pays none. Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 1 Days and SpaceX for 41 Days on average.
| RPRX | SPCX | |
|---|---|---|
Market Cap | $25.27B | $2.18T |
Volume | 3,671,183 | 68,508,567 |
Sector | Health | Industrials |
52-Week High | $63.96 | $202.09 |
52-Week Low | $35.44 | $108.27 |
Typical Hold Time | 1 Days | 41 Days |
Enterprise Value | $32.50B | $2.12T |
Dividend Yield | 1.66% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About SpaceX
SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.
Read more on SPCX →
